For healthcare professionals
Referrals to the NCIMD typically come from the National Newborn Bloodspot Screening Programme, and from tertiary and quaternary sources.
New referrals are accepted within the age-attendance policy of CHI, i.e. up to the eve of the person’s 16th birthday.
The NCIMD is recognised by the European Academy of Paediatrics (EAP) to provide training for medical professionals in paediatric inherited metabolic diseases.